Ginkgo Bioworks Holdings(DNA)在盘后交易中出现大幅下跌,股价大跌14.48%,引发市场广泛关注。
根据新闻报道,Ginkgo Bioworks在最新披露的第四季度财报中,每股亏损为2美元,高于分析师预期的1.77美元亏损。同时公司本季度销售额为4385万美元,也未能达到市场预期的4446万美元。财报数据不佳或成为导致该股盘后大跌的主要原因。
分析人士指出,尽管与去年同期相比财报已有所改善,但Ginkgo Bioworks未能实现分析师预期的盈利和营收目标,这在一定程度上降低了投资者的信心。如果公司下一季度业绩无法好转,股价可能面临进一步下行风险。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.